2025-520790-39-00RecruitingPhase 1
CLonE-specific CAR T-Cell therapy in relapsed or refractory AL amyloidosis - a single-center Phase I trial (CLEAR AL)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 25 Nov 2025
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (estimated)
- First submitted
- 12 Sept 2025
- Start date
- 4 Mar 2026
- Lead sponsor
- Universitaetsklinikum Heidelberg AöR
- Diseases
- Amyloidosis
- EU CT number
- 2025-520790-39-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 7
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitaetsklinikum Heidelberg AöR | Heidelberg | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.